Express Scripts repeats FY14 adjusted EPS view $4.82-$4.94, consensus $4.87 Repeats FY14 adjusted EBITDA view $6.775B-$6.975B. Sees FY14 adjusted EBITDA per adjusted claim $5.20-$5.30. Sees FY14 EPS growth of 17%-20% excluding UNH. Sees FY14 adjusted claims 1.27B-1.33B. Comments from slides that are being presented at the Bank of America Merrill Lynch Healthcare Conference.
News For ESRX From The Last 14 Days
Check below for free stories on ESRX the last two weeks.